Donald W. Nicholson

Merck Canada Inc. (Canada)

Papers

1

Total Citations

3

H-Index

1

About

Donald W. Nicholson is a pioneering figure in the field of apoptosis research, whose work has fundamentally shaped our understanding of programmed cell death and its role in human disease. His major contributions center on the discovery and characterization of caspases—the proteolytic enzymes that execute the apoptotic program—and their critical involvement in neurodegenerative disorders, cancer, and inflammation. Nicholson’s landmark studies established the caspase cascade as a central mechanism in cell death, providing the foundation for developing therapeutic inhibitors targeting these enzymes. His research has been widely influential, with several of his key papers accumulating thousands of citations, reflecting their profound impact on molecular biology and drug discovery. Notably, Nicholson led the team that first identified caspase-3 as a key executioner protease, and his work on the correlation between caspase-3 activity and apoptotic markers, as demonstrated in his 2005 study using NT2 cells, continues to inform experimental approaches in the field. Through his contributions to both basic science and translational medicine, Nicholson has left an enduring legacy in apoptosis research, inspiring generations of scientists exploring cell death pathways.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Correlating the fractional inhibition of caspase-3 in NT2 cells with apoptotic markers using an active-caspase-3 enzyme-linked immunosorbent assay
3 citations · 2005
📈 Most Prolific Year: 2005 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Merck Canada Inc. (Canada)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago